Lux Research analysts report that graphene nanoplatelets are following the same path as multiwall carbon nanotubes. That is there is over capacity of graphene nanoplatelets and limited commercial applications for the materials. They also point out that most companies in the graphene space are not executing well and their technical value is unclear. They don't expect graphene to live up to the hype.
![Image]()
